Masato Suzuoki

Summary

Affiliation: Hokkaido University
Country: Japan

Publications

  1. ncbi request reprint RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma
    Masato Suzuoki
    Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
    Ann Surg Oncol 9:388-93. 2002
  2. pmc Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
    M Suzuoki
    Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Kita 15, Nishi 7, Kita ku, Sapporo, Hokkaido 060 8638 Japan
    Br J Cancer 87:1140-4. 2002
  3. ncbi request reprint Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response
    Taro Oshikiri
    Department of Surgical Oncology, Cancer Medicine, Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
    J Surg Oncol 84:224-8. 2003
  4. ncbi request reprint High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker
    Kei Hiraoka
    Surgical Oncology, Cancer Medicine, Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
    Int J Cancer 99:418-23. 2002
  5. ncbi request reprint CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
    Akira Fukunaga
    Division of Cancer Medicine, Cancer Medicine, and Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Pancreas 28:e26-31. 2004
  6. ncbi request reprint CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma
    Yasushi Cho
    Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Hokkaido 060 8638, Japan
    Cancer Res 63:1555-9. 2003
  7. ncbi request reprint The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus
    Yoshihiro Nakakubo
    Hokkaido University Graduate School of Medicine, Division of Cancer Medicine, Cancer Medicine, Surgical Oncology, N 14, W 5, Sapporo 060 8648, Japan
    Cancer Lett 177:101-5. 2002
  8. ncbi request reprint Treatment of Budd-Chiari syndrome with percutaneous transluminal angioplasty: report of a case
    Masato Suzuoki
    Department of Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Surg Today 32:559-62. 2002

Collaborators

Detail Information

Publications8

  1. ncbi request reprint RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma
    Masato Suzuoki
    Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
    Ann Surg Oncol 9:388-93. 2002
    ..We investigated the relationship between RCAS1 expression and clinicopathologic features and clinical outcome in patients with extrahepatic bile duct carcinoma (EBDC) who underwent curative resection...
  2. pmc Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
    M Suzuoki
    Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Kita 15, Nishi 7, Kita ku, Sapporo, Hokkaido 060 8638 Japan
    Br J Cancer 87:1140-4. 2002
    ..0358). These results suggest that caveolin-1 overexpression is associated with tumour progression, thereby indicating a poor prognosis for certain patients undergoing surgical resection for pancreatic carcinoma...
  3. ncbi request reprint Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response
    Taro Oshikiri
    Department of Surgical Oncology, Cancer Medicine, Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
    J Surg Oncol 84:224-8. 2003
    ..CD8+ T cells have been identified as a prognostic factor in several cancers. Here, we investigate that the influence of CD8+ T cells on extrahepatic bile duct carcinoma (EBDC) patient survival...
  4. ncbi request reprint High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker
    Kei Hiraoka
    Surgical Oncology, Cancer Medicine, Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
    Int J Cancer 99:418-23. 2002
    ..090; p = 0.0090). These results suggested that RCAS1 might be a significant tumor marker for pancreatic adenocarcinoma and an unfavorable predictor for prognosis of patients who have undergone surgical resection...
  5. ncbi request reprint CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
    Akira Fukunaga
    Division of Cancer Medicine, Cancer Medicine, and Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Pancreas 28:e26-31. 2004
    ..In an experimental model, CD4+ lymphocytes together with CD8+ lymphocytes contributed significantly to tumor immunity...
  6. ncbi request reprint CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma
    Yasushi Cho
    Division of Cancer Medicine, Hokkaido University Graduate School of Medicine, Hokkaido 060 8638, Japan
    Cancer Res 63:1555-9. 2003
    ..Multivariate analysis identified CD4/8(+/+) status, T classification, and N classification as independent prognostic factors. In conclusion, cooperation between CD4(+) and CD8(+) T cells correlates strongly with ESCC patient prognosis...
  7. ncbi request reprint The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus
    Yoshihiro Nakakubo
    Hokkaido University Graduate School of Medicine, Division of Cancer Medicine, Cancer Medicine, Surgical Oncology, N 14, W 5, Sapporo 060 8648, Japan
    Cancer Lett 177:101-5. 2002
    ..Multivariate analysis indicated that RCAS1 positivity was an independent negative prognostic factor. Our study establishes RCAS1 as a novel prognostic marker for surgically resected oesophageal squamous cell carcinoma...
  8. ncbi request reprint Treatment of Budd-Chiari syndrome with percutaneous transluminal angioplasty: report of a case
    Masato Suzuoki
    Department of Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Surg Today 32:559-62. 2002
    ..Restenosis occurred at 1 year and 5 years after the initial angioplasty, for which PTA was repeatedly performed. Nine years after the initial treatment, no stenosis has been observed and the patient has shown a favorable outcome...